““The whole purpose of biosimilars was to introduce competition into the marketplace,' said study author Ben Rome. '...The fact that it’s so hard to find savings consistently is disappointing.' statnews.com/pharmalot/2024… #pharma #biotech #biologics #biosimilars #medicines

“Colombia is planting a flag for global health equity,” said Peter Maybarduk of Public Citizen. “This will inspire new challenges to patent barriers and improve treatment access, towards an AIDS-free generation.' statnews.com/pharmalot/2024… #patents #medicines #Colombia #HIV $GSK

“The messages are filled with misinformation that is hard to set straight because it is such a complicated topic and patients are made to feel like their lives are at stake' statnews.com/pharmalot/2024… #pharma #RareDiseases #medicines #drugs #Colorado #Enbrel $AMGN $VRTX

After nearly 30 years covering pharma, you might think I know it all. Here's your chance to find out... you can Ask Me Anything on Thursday, Feb. 15 at 1 pm ET.. click on this STAT+ Connect link to sign up...

connect.statnews.com/landing

CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies.. statnews.com/pharmalot/2024… #pharma #Medicaid #CMS #medicines #sicklecell $VRTX $CRSP $BLUE

Pricey sickle cell treatments raise daunting new challenges for Medicaid programs.. statnews.com/pharmalot/2024… #pharma #sicklecell #Medicaid $VRTX $CRSP $BLUE

When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’.. statnews.com/pharmalot/2024… #pharma #FTC #antitrust #monopoly #Biden #rebates #patents #mergers $CVS $AMGN $UNH $CI $GSK $AZN $SNY

Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace.. statnews.com/pharmalot/2023… #pharma #biotech #biosimilar #patents

‘We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA.. statnews.com/pharmalot/2023… #pharma #biotech #FDA #raredisease #orphandrug

Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?.. my latest column.. feedback, suggestions, criticism are welcome.. statnews.com/2023/10/04/amg…… #pharma #biotech #cancer #FDA #transparency #clinicaltrials $AMGN

Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV.. statnews.com/pharmalot/2023… #pharma #patent #HIV #AIDS #Colombia $GSK $PFE

J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries.. statnews.com/pharmalot/2023… #pharma #patents #TB #tuberculosis #medicine $JNJ

Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines.. read the indictment here.. statnews.com/pharmalot/2023… #pharma #HIV #counterfeit $GILD $JNJ

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results.. statnews.com/pharmalot/2023… #pharma #SEC #insidertrading #Paxlovid $PFE

Gilead defeats federal government in closely watched battle over patents for HIV prevention pills.. statnews.com/pharmalot/2023… #pharma #patents #HIV #AIDS #CDC #HHS $GILD

‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J.. statnews.com/pharmalot/2023… #pharma #diabetes $JNJ

European Union drug pricing proposal for the pandemic treaty generates pushback.. statnews.com/pharmalot/2023… #pharma #pandemic #WHO

Eli Lilly is making some dramatic cuts to list prices of its insulin products.. Matthew Herper & I spoke to CEO David Ricks, and also to several experts and a patient advocate who were hopeful but a bit skeptical. statnews.com/pharmalot/2023… #pharma #diabetes #insulin $LLY $SNY $NVO

“It makes me mad to no end. They put a price on our daughter’s life and it’s financially strained our family.' statnews.com/pharmalot/2023… #pharma #healthcare #cysticfibrosis #copay #insurance $VRTX

Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents.. statnews.com/pharmalot/2023… #pharma #cysticfibrosis #patents $VRTX